35328765|t|Cannabinoids: Therapeutic Use in Clinical Practice.
35328765|a|Medical case reports suggest that cannabinoids extracted from Cannabis sativa have therapeutic effects; however, the therapeutic employment is limited due to the psychotropic effect of its major component, Delta9-tetrahydrocannabinol (THC). The new scientific discoveries related to the endocannabinoid system, including new receptors, ligands, and mediators, allowed the development of new therapeutic targets for the treatment of several pathological disorders minimizing the undesirable psychotropic effects of some constituents of this plant. Today, FDA-approved drugs, such as nabiximols (a mixture of THC and non-psychoactive cannabidiol (CBD)), are employed in alleviating pain and spasticity in multiple sclerosis. Dronabinol and nabilone are used for the treatment of chemotherapy-induced nausea and vomiting in cancer patients. Dronabinol was approved for the treatment of anorexia in patients with AIDS (acquired immune deficiency syndrome). In this review, we highlighted the potential therapeutic efficacy of natural and synthetic cannabinoids and their clinical relevance in cancer, neurodegenerative and dermatological diseases, and viral infections.
35328765	0	12	Cannabinoids	Chemical	MESH:D002186
35328765	86	98	cannabinoids	Chemical	MESH:D002186
35328765	114	129	Cannabis sativa	Species	3483
35328765	258	285	Delta9-tetrahydrocannabinol	Chemical	MESH:D013759
35328765	287	290	THC	Chemical	MESH:D013759
35328765	339	354	endocannabinoid	Chemical	MESH:D063388
35328765	505	514	disorders	Disease	MESH:D009358
35328765	634	644	nabiximols	Chemical	MESH:C587251
35328765	659	662	THC	Chemical	MESH:D013759
35328765	684	695	cannabidiol	Chemical	MESH:D002185
35328765	697	700	CBD	Chemical	MESH:D002185
35328765	732	736	pain	Disease	MESH:D010146
35328765	741	751	spasticity	Disease	MESH:D009128
35328765	755	773	multiple sclerosis	Disease	MESH:D009103
35328765	775	785	Dronabinol	Chemical	MESH:D013759
35328765	790	798	nabilone	Chemical	MESH:C011941
35328765	850	869	nausea and vomiting	Disease	MESH:D020250
35328765	873	879	cancer	Disease	MESH:D009369
35328765	880	888	patients	Species	9606
35328765	890	900	Dronabinol	Chemical	MESH:D013759
35328765	935	943	anorexia	Disease	MESH:D000855
35328765	947	955	patients	Species	9606
35328765	961	965	AIDS	Disease	MESH:D000163
35328765	967	1002	acquired immune deficiency syndrome	Disease	MESH:D000163
35328765	1096	1108	cannabinoids	Chemical	MESH:D002186
35328765	1141	1147	cancer	Disease	MESH:D009369
35328765	1149	1194	neurodegenerative and dermatological diseases	Disease	MESH:D019636
35328765	1200	1216	viral infections	Disease	MESH:D014777
35328765	Negative_Correlation	MESH:C587251	MESH:D009128
35328765	Negative_Correlation	MESH:D013759	MESH:D000163
35328765	Association	MESH:D063388	MESH:D009358
35328765	Negative_Correlation	MESH:D002185	MESH:D009128
35328765	Negative_Correlation	MESH:C011941	MESH:D020250
35328765	Comparison	MESH:D002185	MESH:D013759
35328765	Negative_Correlation	MESH:D002186	MESH:D019636
35328765	Negative_Correlation	MESH:D013759	MESH:D009369
35328765	Negative_Correlation	MESH:D013759	MESH:D009103
35328765	Negative_Correlation	MESH:C011941	MESH:D009369
35328765	Negative_Correlation	MESH:D002185	MESH:D010146
35328765	Negative_Correlation	MESH:D013759	MESH:D000855
35328765	Negative_Correlation	MESH:C587251	MESH:D010146
35328765	Association	MESH:D002186	MESH:D014777
35328765	Negative_Correlation	MESH:D002185	MESH:D009103
35328765	Negative_Correlation	MESH:C587251	MESH:D009103
35328765	Negative_Correlation	MESH:D013759	MESH:D020250
35328765	Negative_Correlation	MESH:D013759	MESH:D009128
35328765	Negative_Correlation	MESH:D002186	MESH:D009369

